These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4325386)

  • 1. Efficacy of isoproterenol-glucagon infusion in patients with heart disease.
    Polumbo RA; Leighton RF; Weissler AM
    Circulation; 1971 Jun; 43(6):786-91. PubMed ID: 4325386
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic evaluation of glucagon in symptomatic heart disease.
    Armstrong PW; Gold HK; Daggett WM; Austen WG; Sanders CA
    Circulation; 1971 Jul; 44(1):67-73. PubMed ID: 4934830
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoproterenol in treatment of heart disease. Hemodynamic effects in circulatory failure.
    Elliott WC; Gorlin R
    JAMA; 1966 Aug; 197(5):315-20. PubMed ID: 5952837
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of lidocaine.
    Cullhed I
    Isr J Med Sci; 1969; 5(4):750-3. PubMed ID: 5820510
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sympathomimetics in the management of postoperative cardiac insufficiency: effect on blood circulation and oxygen uptake].
    Rothlin M; Gattiker R; Hossli G
    Schweiz Med Wochenschr; 1968 Aug; 98(33):1229-32. PubMed ID: 5682100
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of diuretics on renin activity in cardiac insufficiency].
    Vinogradov AV; Kuz'mina AE
    Kardiologiia; 1971 Oct; 11(10):46-50. PubMed ID: 5138044
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic effects of a combination of theophylline and ethylenediamine in heart failure with pulmonary hypertension].
    Klein W
    Arzneimittelforschung; 1969 Sep; 19(9):1559-62. PubMed ID: 5394532
    [No Abstract]   [Full Text] [Related]  

  • 8. A role for glucagon in cardiac therapy.
    Parmley WW; Sonnenblick EH
    Am J Med Sci; 1969 Oct; 258(4):224-9. PubMed ID: 4309903
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacodynamic studies in aortic regurgitation.
    Kloster FE; Bristow JD; Lewis RP; Griswold HE
    Am J Cardiol; 1967 May; 19(5):644-52. PubMed ID: 6023460
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac reserve during isoproterenol stress in patients with aortic valve disease before and after corrective surgery.
    Schwarz F; Flameng W; Thormann J; Ensslen R; Sesto M; Schlepper M
    Am Heart J; 1978 Feb; 95(2):146-53. PubMed ID: 622949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacodynamic effect of a beta-blocking agent, trasicor, in normal subjects and in subjects with valvular cardiopathy].
    Bensaïd J; Castan R; Sozutek Y; Scebat L; Lenègre J
    Arch Mal Coeur Vaiss; 1969 Oct; 62(10):1404-23. PubMed ID: 4252308
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
    Jewitt D; Birkhead J; Mitchell A; Dollery C
    Lancet; 1974 Aug; 2(7877):363-7. PubMed ID: 4136593
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic effects of low-dose isoproterenol and aminophylline after coronary embolization in dogs.
    Falicov RE; Lipp H; Resnekov L; King S
    Cardiovasc Res; 1973 Jan; 7(1):63-8. PubMed ID: 4694958
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effects of phentolamine in valvular abnormalities.
    Gould L; Reddy CV; Kim SG; Oh KC
    Angiology; 1978 Dec; 29(12):898-906. PubMed ID: 742729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some practical problems of cardiac glycoside therapy].
    Szám I
    Orv Hetil; 1969 Feb; 110(7):366-71. PubMed ID: 5780287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of the Asparagin preparation].
    Stasiński T; Olejniczak P; Biryńczyk J; Dyszkiewicz B; Horn-Maciejewska M; Polarczyk Z; Dyczkowski A; Krzyśko M
    Pol Tyg Lek; 1973 Jul; 28(25):953-5. PubMed ID: 4721470
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic effects of glucagon in patients with heart disease.
    Williams JF; Childress RH; Chip JN; Border JF
    Circulation; 1969 Jan; 39(1):38-47. PubMed ID: 5782807
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of myocardial flow, hemodynamic changes, and lactate metabolism during isoproterenol stress in patients with coronary heart disease and severe aortic stenosis.
    Thormann J; Schlepper M
    Clin Cardiol; 1979 Dec; 2(6):437-45. PubMed ID: 544112
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of glucagon on resting and exercise haemodynamics in patients with coronary heart disease.
    Greenberg BH; McCallister BD; Frye RL
    Br Heart J; 1972 Sep; 34(9):924-9. PubMed ID: 5075311
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic effects of glucagon.
    Murtagh JG; Binnion PF; Lal S; Hutchison KJ; Fletcher E
    Br Heart J; 1970 May; 32(3):307-15. PubMed ID: 5420074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.